Global Newcastle Disease Vaccine Market Research Report 2017

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 111

Report ID: 118174

In this report, the global Newcastle Disease Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Newcastle Disease Vaccine in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Newcastle Disease Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merial
QYH Biotech
DHN
HVRI
CEVA
Elanco
Yebio
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
ChengDu Tecbond
Sindh Poultry Vaccine Centre
Merck Animal Health
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Live Vaccines
Killed Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Newcastle Disease Vaccine for each application, including
Chicken
Duck & Goose
Other

Table of Contents

Global Newcastle Disease Vaccine Market Research Report 2017
1 Newcastle Disease Vaccine Market Overview
1.1 Product Overview and Scope of Newcastle Disease Vaccine
1.2 Newcastle Disease Vaccine Segment by Type (Product Category)
1.2.1 Global Newcastle Disease Vaccine Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Newcastle Disease Vaccine Production Market Share by Type (Product Category) in 2016
1.2.3 Live Vaccines
1.2.4 Killed Vaccines
1.3 Global Newcastle Disease Vaccine Segment by Application
1.3.1 Newcastle Disease Vaccine Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Newcastle Disease Vaccine Market by Region (2012-2022)
1.4.1 Global Newcastle Disease Vaccine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Newcastle Disease Vaccine (2012-2022)
1.5.1 Global Newcastle Disease Vaccine Revenue Status and Outlook (2012-2022)
1.5.2 Global Newcastle Disease Vaccine Capacity, Production Status and Outlook (2012-2022)

2 Global Newcastle Disease Vaccine Market Competition by Manufacturers
2.1 Global Newcastle Disease Vaccine Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Newcastle Disease Vaccine Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Newcastle Disease Vaccine Production and Share by Manufacturers (2012-2017)
2.2 Global Newcastle Disease Vaccine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Newcastle Disease Vaccine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Newcastle Disease Vaccine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Newcastle Disease Vaccine Market Competitive Situation and Trends
2.5.1 Newcastle Disease Vaccine Market Concentration Rate
2.5.2 Newcastle Disease Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Newcastle Disease Vaccine Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Newcastle Disease Vaccine Capacity and Market Share by Region (2012-2017)
3.2 Global Newcastle Disease Vaccine Production and Market Share by Region (2012-2017)
3.3 Global Newcastle Disease Vaccine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Newcastle Disease Vaccine Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Newcastle Disease Vaccine Consumption by Region (2012-2017)
4.2 North America Newcastle Disease Vaccine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Newcastle Disease Vaccine Production, Consumption, Export, Import (2012-2017)
4.4 China Newcastle Disease Vaccine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Newcastle Disease Vaccine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Newcastle Disease Vaccine Production, Consumption, Export, Import (2012-2017)
4.7 India Newcastle Disease Vaccine Production, Consumption, Export, Import (2012-2017)

5 Global Newcastle Disease Vaccine Production, Revenue (Value), Price Trend by Type
5.1 Global Newcastle Disease Vaccine Production and Market Share by Type (2012-2017)
5.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2012-2017)
5.3 Global Newcastle Disease Vaccine Price by Type (2012-2017)
5.4 Global Newcastle Disease Vaccine Production Growth by Type (2012-2017)

6 Global Newcastle Disease Vaccine Market Analysis by Application
6.1 Global Newcastle Disease Vaccine Consumption and Market Share by Application (2012-2017)
6.2 Global Newcastle Disease Vaccine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Newcastle Disease Vaccine Manufacturers Profiles/Analysis
7.1 Merial
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Merial Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 QYH Biotech
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 QYH Biotech Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 DHN
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 DHN Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 HVRI
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 HVRI Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 CEVA
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 CEVA Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Elanco
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Elanco Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Yebio
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Yebio Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Zoetis
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Zoetis Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 FATRO
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 FATRO Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Kyoto Biken
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Newcastle Disease Vaccine Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Kyoto Biken Newcastle Disease Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 CAVAC
7.12 Ringpu Biology
7.13 Vaksindo
7.14 ChengDu Tecbond
7.15 Sindh Poultry Vaccine Centre
7.16 Merck Animal Health

8 Newcastle Disease Vaccine Manufacturing Cost Analysis
8.1 Newcastle Disease Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Newcastle Disease Vaccine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Newcastle Disease Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Newcastle Disease Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Newcastle Disease Vaccine Market Forecast (2017-2022)
12.1 Global Newcastle Disease Vaccine Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Newcastle Disease Vaccine Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Newcastle Disease Vaccine Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Newcastle Disease Vaccine Price and Trend Forecast (2017-2022)
12.2 Global Newcastle Disease Vaccine Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Newcastle Disease Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Newcastle Disease Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Newcastle Disease Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Newcastle Disease Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Newcastle Disease Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Newcastle Disease Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Newcastle Disease Vaccine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Newcastle Disease Vaccine Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer